Ubs Oconnor LLC Protalix Bio Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$3.58 - $6.45 $1.06 Million - $1.9 Million	295,171 Added 196.78%	445,171 $1.99 Million
Q4 2020 Feb 17, 2021	SELL	$3.15 - $3.98 $472,500 - $597,000	-150,000 Reduced 50.0%	150,000 $544,000
Q3 2020 Nov 12, 2020	SELL	$3.37 - $3.93 $1.25 Million - $1.46 Million	-372,035 Reduced 55.36%	300,000 $1.16 Million
Q2 2020 Aug 13, 2020	BUY	$2.19 - $4.5 $1.47 Million - $3.02 Million	672,035 New	672,035 $2.55 Million

5.61M

103K

4.6K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $53.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.